This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
PAVmed Crescita futura
Future criteri di controllo 2/6
PAVmed is forecast to grow earnings and revenue by 24.4% and 49.2% per annum respectively while EPS is expected to grow by 44.5% per annum.
Informazioni chiave
24.4%
Tasso di crescita degli utili
44.5%
Tasso di crescita dell'EPS
Medical Equipment crescita degli utili | 15.8% |
Tasso di crescita dei ricavi | 49.2% |
Rendimento futuro del capitale proprio | n/a |
Copertura analitica | Low |
Ultimo aggiornamento | 09 Dec 2023 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Previsioni di crescita degli utili e dei ricavi
Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
---|---|---|---|---|---|
12/31/2026 | 128 | -10 | 4 | N/A | 1 |
12/31/2025 | 29 | -56 | -42 | N/A | 2 |
12/31/2024 | 8 | -60 | -62 | -12 | 4 |
12/31/2023 | 2 | -68 | -65 | -53 | 4 |
9/30/2023 | 2 | -71 | -57 | -57 | N/A |
6/30/2023 | 1 | -79 | -66 | -65 | N/A |
3/31/2023 | 1 | -90 | -76 | -75 | N/A |
12/31/2022 | 0 | -89 | -73 | -71 | N/A |
9/30/2022 | 1 | -86 | -73 | -71 | N/A |
6/30/2022 | 1 | -72 | -62 | -60 | N/A |
3/31/2022 | 1 | -58 | -46 | -44 | N/A |
12/31/2021 | 1 | -51 | -42 | -41 | N/A |
9/30/2021 | 0 | -42 | -31 | -31 | N/A |
6/30/2021 | N/A | -35 | -29 | -28 | N/A |
3/31/2021 | N/A | -30 | -27 | -27 | N/A |
12/31/2020 | N/A | -35 | -22 | -22 | N/A |
9/30/2020 | N/A | -32 | -19 | -19 | N/A |
6/30/2020 | N/A | -30 | -16 | -16 | N/A |
3/31/2020 | N/A | -28 | -13 | -13 | N/A |
12/31/2019 | N/A | -17 | -13 | -13 | N/A |
9/30/2019 | N/A | -17 | -12 | -12 | N/A |
6/30/2019 | N/A | -17 | -11 | -11 | N/A |
3/31/2019 | N/A | -19 | -10 | -10 | N/A |
12/31/2018 | N/A | -19 | -9 | -9 | N/A |
9/30/2018 | N/A | -12 | -7 | -7 | N/A |
6/30/2018 | N/A | -14 | -8 | -8 | N/A |
3/31/2018 | N/A | -10 | -7 | -7 | N/A |
12/31/2017 | N/A | -10 | -7 | -7 | N/A |
9/30/2017 | N/A | -12 | -6 | -6 | N/A |
6/30/2017 | N/A | -9 | N/A | -5 | N/A |
3/31/2017 | N/A | -9 | N/A | -6 | N/A |
12/31/2016 | N/A | -6 | N/A | -4 | N/A |
9/30/2016 | N/A | -5 | N/A | -4 | N/A |
6/30/2016 | N/A | -3 | N/A | -3 | N/A |
3/31/2016 | N/A | -2 | N/A | -2 | N/A |
12/31/2015 | N/A | -2 | N/A | -1 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: 1P50 is forecast to remain unprofitable over the next 3 years.
Guadagni vs Mercato: 1P50 is forecast to remain unprofitable over the next 3 years.
Guadagni ad alta crescita: 1P50 is forecast to remain unprofitable over the next 3 years.
Ricavi vs Mercato: 1P50's revenue (49.2% per year) is forecast to grow faster than the German market (5.1% per year).
Ricavi ad alta crescita: 1P50's revenue (49.2% per year) is forecast to grow faster than 20% per year.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Insufficient data to determine if 1P50's Return on Equity is forecast to be high in 3 years time